Resources
A student hypothesizes that overexpressing the multidrug resistance transporter gene ABCB1 (P-glycoprotein) will uniformly decrease the intracellular concentration of all hydrophobic chemotherapeutic agents. In a cultured leukemic cell line, ABCB1 expression increases -fold, leading to an active drug efflux clearance rate of for daunorubicin. However, for a second hydrophobic agent, drug , the transporter exhibits zero substrate affinity (), while drug passively diffuses across the membrane at an influx permeability-surface area product of without active export. If the extracellular concentration of drug is maintained at , calculate the steady-state intracellular concentration of drug in in the ABCB1-overexpressing cells, assuming equilibrium passive diffusion across the plasma membrane.
Answer and steps
Final answer
Steps
Identify the Transporter Specificity for Drug
Transporters such as P-glycoprotein (encoded by the ABCB1 gene) depend on specific substrate binding to catalyze active efflux. The affinity of an enzyme or transporter for a compound is reflected inversely by its Michaelis constant, :
- For daunorubicin, ABCB1 overexpression mediates active drug clearance ().
- For drug , the transporter exhibits zero affinity (). Consequently, P-glycoprotein cannot engage drug , making the active efflux clearance for drug zero:
Formulate the Mass Balance for Passive Diffusion at Steady State
Because active transport does not occur for drug , its movement across the plasma membrane is governed solely by passive bidirectional diffusion.
The passive influx rate () and passive efflux rate () are given by Fick's first law using the permeability-surface area product ():
At steady-state equilibrium, the net flux across the membrane is zero:
Calculate the Intracellular Concentration
Dividing by simplifies the equation to:
Given that :
Key Takeaway: A gene expression change (such as ABCB1 overexpression) alters cellular phenotype only for ligands or substrates recognized by the encoded protein. Hydrophobicity alone is insufficient for transport; without substrate specificity, passive equilibrium dictates that intracellular and extracellular concentrations remain equal.
Typical errors
01 The student erroneously applies the active efflux clearance of daunorubicin to drug X despite drug X having zero substrate affinity for the transporter.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1Correct
You included an active efflux clearance term () for drug . However, the problem specifies that drug has zero substrate affinity for ABCB1 () and undergoes no active export, meaning .
- Step 2Correct
You substituted the active efflux clearance value determined for daunorubicin ( into the formula for drug , which carried forward the assumption of active transport.
- Step 3Correct
You evaluated the arithmetic correctly for your substituted expression, but the resulting concentration is incorrect due to the inclusion of daunorubicin's efflux clearance.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly formulated the general steady-state mass balance between passive influx and total clearance.
You solved for the intracellular concentration algebraically before substituting values.
You executed the arithmetic calculation accurately based on your substituted numbers.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou assumed that overexpressing ABCB1 universally confers active efflux to all hydrophobic molecules, overlooking that transporter-mediated clearance strictly requires substrate recognition and binding affinity ().
REASONING PATH
Your ACEpath teacher’s suggested approach- Transporter Substrate Specificity
Active transport requires specific chemical recognition and binding; high hydrophobicity alone does not guarantee that a compound is an ABCB1 substrate if .
Check whether the specific molecule has documented affinity () for the transporter before assigning an active efflux rate.
- Passive Equilibrium Balance
In the absence of active transport, passive bidirectional diffusion across a membrane continues until intracellular and extracellular concentrations equalize ().
Set whenever a transporter cannot bind the solute, reducing the flux balance directly to .
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify that drug has zero affinity for ABCB1 (), so its active efflux clearance is .
Write the steady-state flux balance governed exclusively by passive diffusion: .
Divide both sides by to obtain .
Substitute directly.
02 The student assumes the 10.0-fold overexpression of ABCB1 universally reduces the intracellular drug concentration by a factor of 10.0.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1Correct
You applied the 10.0-fold gene overexpression factor universally to reduce the intracellular concentration of drug . Because the problem specifies that the transporter has zero substrate affinity () for drug , the transporter cannot pump drug out regardless of how heavily ABCB1 is overexpressed.
- Step 2Correct
You calculated by evaluating your incorrect relation. Under uninhibited passive diffusion equilibrium, equals , which is .
WHAT YOU DID WELL
Compliments from Your TeacherYou identified the extracellular concentration from the problem statement.
You carried out your arithmetic division correctly.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakenone
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou assumed that overexpressing a transport protein automatically alters the distribution of all hydrophobic molecules, overlooking the requirement for specific substrate-transporter binding ().
REASONING PATH
Your ACEpath teacher’s suggested approach- Substrate Specificity of Transport Proteins
An active transporter only changes cellular drug levels if the drug is an actual substrate (finite ). If , active clearance is zero.
Always check whether the molecule of interest binds the transporter before applying any clearance or expression-level fold changes.
- Passive Diffusion Equilibrium
For an uncharged solute moving solely by passive diffusion across a membrane, steady-state net flux is zero when .
Set intracellular concentration equal to extracellular concentration when no active transport, metabolism, or electrochemical gradients are present.
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify that zero substrate affinity () means active efflux clearance for drug is .
Write the steady-state passive diffusion flux balance: .
Solve for the intracellular concentration: .
Lock it in
Does overexpressing an active efflux transporter (e.g., P-glycoprotein) lower the intracellular concentration of every hydrophobic solute?
No. Active efflux requires specific substrate binding affinity; if , the transporter cannot bind or pump the solute regardless of hydrophobicity.
Similar question
A leukemic cell line overexpresses ABCB1. Drug is a known P-glycoprotein substrate with active efflux clearance and passive permeability . If , calculate the steady-state intracellular concentration in .
Answer
. Set up the steady-state flux balance: . Rearranging gives .
Cells expressing the transporter BCRP () are exposed to hydrophobic Drug (, ). Competitive binding assays show Drug does not bind BCRP (). An inhibitor of BCRP is then added to the medium. Does the intracellular concentration of Drug change? Explain quantitatively.
Answer
No, remains . Because Drug has zero affinity for BCRP, its active efflux clearance was already zero (). Thus, passive diffusion maintained , and inhibiting BCRP has no effect on its transport.
A cell line actively imports Solute via a saturable influx carrier with and . Solute also diffuses passively in both directions with , and has zero affinity for all efflux pumps. If at steady state, calculate in .
Answer
. Total influx equals passive influx plus carrier-mediated influx: . At steady state with passive efflux only: . Therefore, .